Fentanyl Citrate, Bupivacaine HCl

Product NDC: 52533-080
11-digit product format: 525330080
Labeler code: 52533
Product ID: 52533-080_f3254ff6-b17a-4687-b8c2-3bff073b440e
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: Fentanyl Citrate, Bupivacaine HCl
Dosage form: INJECTION, SOLUTION
Route: EPIDURAL
Labeler: Cantrell Drug Company
Marketing category: UNAPPROVED DRUG OTHER
Marketing start: 2013-03-25
Marketing end: 0000-00-00
Substance: FENTANYL CITRATE; BUPIVACAINE HYDROCHLORIDE
Active strength: 2 ug/mL; mg/mL
Pharmacologic classes: Full Opioid Agonists [MoA],Opioid Agonist [EPC],Amide Local Anesthetic [EPC],Amides [CS],Local Anesthesia [PE]
DEA schedule: CII
NDC exclude flag: E
Listing certified through: 2017-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 12 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Source date
excluded product	product	52533-080		I	Inactivated by FDA	2026-10-05
excluded product	product	52533-080		I	Inactivated by FDA	2026-10-05
excluded product	product	52533-080		D	Discontinued by firm	2026-10-05
excluded product	product	52533-080		I	Inactivated by FDA	2026-10-05
excluded product	product	52533-080		D	Discontinued by firm	2026-10-05
excluded product	product	52533-080		I	Inactivated by FDA	2026-10-05
excluded package	package	52533-080	52533-080-64	I	Inactivated by FDA	2026-10-05
excluded package	package	52533-080	52533-080-11	I	Inactivated by FDA	2026-10-05
excluded package	package	52533-080	52533-080-01	D	Discontinued by firm	2026-10-05
excluded package	package	52533-080	52533-080-61	I	Inactivated by FDA	2026-10-05
excluded package	package	52533-080	52533-080-71	D	Discontinued by firm	2026-10-05
excluded package	package	52533-080	52533-080-75	I	Inactivated by FDA	2026-10-05

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 4 · 224 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Code	Status	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		I	Inactivated by FDA	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		D	Discontinued by firm	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		I	Inactivated by FDA	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		I	Inactivated by FDA	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		I	Inactivated by FDA	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		D	Discontinued by firm	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	52533-080-71	D	Discontinued by firm	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	52533-080-64	I	Inactivated by FDA	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	52533-080-75	I	Inactivated by FDA	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	52533-080-11	I	Inactivated by FDA	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	52533-080-61	I	Inactivated by FDA	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	52533-080-01	D	Discontinued by firm	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		D	Discontinued by firm	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		D	Discontinued by firm	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	52533-080-71	D	Discontinued by firm	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	52533-080-64	I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	52533-080-75	I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	52533-080-11	I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	52533-080-61	I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	52533-080-01	D	Discontinued by firm	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		D	Discontinued by firm	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		D	Discontinued by firm	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	52533-080-71	D	Discontinued by firm	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	52533-080-64	I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	52533-080-75	I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	52533-080-11	I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	52533-080-61	I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	52533-080-01	D	Discontinued by firm	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		D	Discontinued by firm	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		D	Discontinued by firm	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	52533-080-71	D	Discontinued by firm	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	52533-080-64	I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	52533-080-75	I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	52533-080-11	I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	52533-080-61	I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	52533-080-01	D	Discontinued by firm	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		D	Discontinued by firm	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		D	Discontinued by firm	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	52533-080-71	D	Discontinued by firm	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	52533-080-64	I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	52533-080-75	I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	52533-080-11	I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	52533-080-61	I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	52533-080-01	D	Discontinued by firm	`cfe11265f3b6…`	`090c488252e2…`

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
cbf85893-59ef-423f-87d4-a573c000a8b9	Product name	8	20250731
5dad6767-dcd1-b0da-8727-7f3f7bc3a435	Product name	2	20250303
362d7abb-94e6-4c60-9a58-266894157713	Product name	1	20231023
77d14d2b-b9bf-4254-8dd6-c60dedb281d3	Product name	1	20231002
6bd95106-a412-1dad-b9cc-4cb74bfb27ce	Product name	2	20230315
e3a99641-4540-4894-9108-00cab3c57b7e	Product name	1	20211207
f1e0dc7e-7d61-4625-b6d9-4894927679d7	Product name	2	20211025
5da98533-f072-406b-9e1b-6ac19eca9926	Product name	1	20210622
306b993e-3140-4823-ad5e-88b708f9d2ac	Product name	1	20210510
e4870509-7e28-6f92-f0be-dd3dd889a9cf	Product name	5	20200810
a831e694-3663-4a83-82be-6c309429f750	Product name	2	20200608
a8df478d-5b88-9654-981b-87dff14dda8b	Product name	2	20190801
6e9d4a47-c464-b93e-aebc-ad7bffc9c4cd	Product name	2	20190619
444b3e50-f226-46ef-bfca-2e7035d140cd	Product name	1	20190611
816b97af-edc5-4060-aff1-b814bdbcad50	Product name	1	20190415
7cda52fc-125f-421c-8fea-bc1974370c49	Product name	2	20180703
e9b48db2-e05b-8c2d-e4ac-a5a2efb26b57	Product name	2	20180118
419aab54-5d5a-4146-9453-026d4a9991be	Product name	2	20170525
bb365072-425e-ca0a-021e-fd8b78162502	Product name	2	20161228
339915c8-cc8f-ceb4-1d3f-5ea267d21ea6	Product name	2	20160104
d5e51f11-ad28-caa4-4b49-4143974782ad	Product name	1	20150831
290f523a-f9db-9774-b5a9-e1f908ac1782	Product name	1	20150828
89dac932-b90a-4410-9ab1-84c53e57de25	Product name	1	20150316
5668b646-cd56-c3c7-bdea-3f6b1a8840db	Product name	1	20140508
684ea482-2e8b-14af-5664-b98f1e402036	Product name	1	20140508
739fa0ac-b690-63c4-9904-e20dffbf78f9	Product name	1	20140508
7763fcbb-367d-ed06-b37f-e1529b6241be	Product name	1	20140508
810ab97e-f109-f41c-7c83-6a652a9cbf43	Product name	1	20140508
87711080-88eb-65c5-b2dd-bf99e700a372	Product name	1	20140508
8dbefedf-0a0d-a224-5a3c-66dc9e11c2dd	Product name	1	20140508
b060cc1a-fe47-856b-0b77-4448b5963de8	Product name	1	20140508
c6b65c52-69c7-df49-550a-a50c137f6218	Product name	1	20140508
d9ff6610-5d2e-d5c8-8a19-867d4a1efb77	Product name	1	20140508
ec2149b3-5c6d-5344-f757-c86411073075	Product name	1	20140508
ed912195-5da0-0f2f-6f4b-3ef17710cbe3	Product name	1	20140508

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Indexing SPL table
NDC	Effective	Indexing SPL	Related label
52533-080-64	2020-01-31	9d75b9d0-8587-f424-e053-dadaa90a57ce	Fentanyl Citrate 2 mcg/mL & Bupivacaine HCl 0.125% in 0.9% Sodium Chloride 125 mL Bag
52533-080-75	2020-01-31	9d75b9d0-dcc6-f424-e053-dadaa90a57ce	Fentanyl Citrate 2 mcg/mL & Bupivacaine HCl 0.125% in 0.9% Sodium Chloride 100 mL Bag
52533-080-11	2019-11-27	9855e2a2-3d50-60a7-e053-dbdaa90a05bd	Fentanyl Citrate 2 mcg/mL & Bupivacaine HCl 0.125% in 0.9% Sodium Chloride 250 mL Bag
52533-080-61	2019-11-27	9855e2a2-4e45-60a7-e053-dbdaa90a05bd	Fentanyl Citrate 2 mcg/mL & Bupivacaine HCl 0.125% in 0.9% Sodium Chloride 250 mL Bag

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	SPL version
52533-080-61	Fentanyl Citrate, Bupivacaine HCl	250 mL in 1 BAG	INJECTION, SOLUTION	250	8
52533-080-75	Fentanyl Citrate, Bupivacaine HCl	100 mL in 1 BAG	INJECTION, SOLUTION	100	5
52533-080-11	Fentanyl Citrate, Bupivacaine HCl	250 mL in 1 BAG	INJECTION, SOLUTION	250	3
52533-080-64	Fentanyl Citrate, Bupivacaine HCl	125 mL in 1 BAG	INJECTION, SOLUTION	125	2

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
BUPIVACAINE HYDROCHLORIDE	ACTIVE INGREDIENT	7TQO7W3VT8	FENTANYL CITRATE, BUPIVACAINE HCL INJECTION, SOLUTION [CANTRELL DRUG COMPANY]	8
Fentanyl Citrate	ACTIVE INGREDIENT	MUN5LYG46H	FENTANYL CITRATE, BUPIVACAINE HCL INJECTION, SOLUTION [CANTRELL DRUG COMPANY]	8
BUPIVACAINE	ACTIVE MOIETY	Y8335394RO	FENTANYL CITRATE, BUPIVACAINE HCL INJECTION, SOLUTION [CANTRELL DRUG COMPANY]	8
Fentanyl	ACTIVE MOIETY	UF599785JZ	FENTANYL CITRATE, BUPIVACAINE HCL INJECTION, SOLUTION [CANTRELL DRUG COMPANY]	8
Sodium Chloride	INACTIVE INGREDIENT	451W47IQ8X	FENTANYL CITRATE, BUPIVACAINE HCL INJECTION, SOLUTION [CANTRELL DRUG COMPANY]	8
Water	INACTIVE INGREDIENT	059QF0KO0R	FENTANYL CITRATE, BUPIVACAINE HCL INJECTION, SOLUTION [CANTRELL DRUG COMPANY]	8
BUPIVACAINE HYDROCHLORIDE	ACTIVE INGREDIENT	7TQO7W3VT8	FENTANYL CITRATE, BUPIVACAINE HCL INJECTION, SOLUTION [CANTRELL DRUG COMPANY]	5
Fentanyl Citrate	ACTIVE INGREDIENT	MUN5LYG46H	FENTANYL CITRATE, BUPIVACAINE HCL INJECTION, SOLUTION [CANTRELL DRUG COMPANY]	5
BUPIVACAINE	ACTIVE MOIETY	Y8335394RO	FENTANYL CITRATE, BUPIVACAINE HCL INJECTION, SOLUTION [CANTRELL DRUG COMPANY]	5
Fentanyl	ACTIVE MOIETY	UF599785JZ	FENTANYL CITRATE, BUPIVACAINE HCL INJECTION, SOLUTION [CANTRELL DRUG COMPANY]	5
Sodium Chloride	INACTIVE INGREDIENT	451W47IQ8X	FENTANYL CITRATE, BUPIVACAINE HCL INJECTION, SOLUTION [CANTRELL DRUG COMPANY]	5
Water	INACTIVE INGREDIENT	059QF0KO0R	FENTANYL CITRATE, BUPIVACAINE HCL INJECTION, SOLUTION [CANTRELL DRUG COMPANY]	5
BUPIVACAINE HYDROCHLORIDE	ACTIVE INGREDIENT	7TQO7W3VT8	FENTANYL CITRATE, BUPIVACAINE HCL INJECTION, SOLUTION [CANTRELL DRUG COMPANY]	3
Fentanyl Citrate	ACTIVE INGREDIENT	MUN5LYG46H	FENTANYL CITRATE, BUPIVACAINE HCL INJECTION, SOLUTION [CANTRELL DRUG COMPANY]	3
BUPIVACAINE	ACTIVE MOIETY	Y8335394RO	FENTANYL CITRATE, BUPIVACAINE HCL INJECTION, SOLUTION [CANTRELL DRUG COMPANY]	3
Fentanyl	ACTIVE MOIETY	UF599785JZ	FENTANYL CITRATE, BUPIVACAINE HCL INJECTION, SOLUTION [CANTRELL DRUG COMPANY]	3
Sodium Chloride	INACTIVE INGREDIENT	451W47IQ8X	FENTANYL CITRATE, BUPIVACAINE HCL INJECTION, SOLUTION [CANTRELL DRUG COMPANY]	3
WATER	INACTIVE INGREDIENT	059QF0KO0R	FENTANYL CITRATE, BUPIVACAINE HCL INJECTION, SOLUTION [CANTRELL DRUG COMPANY]	3
BUPIVACAINE HYDROCHLORIDE	ACTIVE INGREDIENT	7TQO7W3VT8	FENTANYL CITRATE, BUPIVACAINE HCL INJECTION, SOLUTION [CANTRELL DRUG COMPANY]	2
Fentanyl Citrate	ACTIVE INGREDIENT	MUN5LYG46H	FENTANYL CITRATE, BUPIVACAINE HCL INJECTION, SOLUTION [CANTRELL DRUG COMPANY]	2
BUPIVACAINE	ACTIVE MOIETY	Y8335394RO	FENTANYL CITRATE, BUPIVACAINE HCL INJECTION, SOLUTION [CANTRELL DRUG COMPANY]	2
Fentanyl	ACTIVE MOIETY	UF599785JZ	FENTANYL CITRATE, BUPIVACAINE HCL INJECTION, SOLUTION [CANTRELL DRUG COMPANY]	2
Sodium Chloride	INACTIVE INGREDIENT	451W47IQ8X	FENTANYL CITRATE, BUPIVACAINE HCL INJECTION, SOLUTION [CANTRELL DRUG COMPANY]	2
Water	INACTIVE INGREDIENT	059QF0KO0R	FENTANYL CITRATE, BUPIVACAINE HCL INJECTION, SOLUTION [CANTRELL DRUG COMPANY]	2

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
52533-080	FENTANYL CITRATE, BUPIVACAINE HCL INJECTION, SOLUTION [CANTRELL DRUG COMPANY]	8	Legacy NDC, 1 package rows	20140813_cfecc5f4-5ce0-46d5-b1d4-92654246fcb2.zip
52533-080	FENTANYL CITRATE, BUPIVACAINE HCL INJECTION, SOLUTION [CANTRELL DRUG COMPANY]	5	Legacy NDC, 1 package rows	20150113_33c34be1-4871-4f0a-9f52-f9606c87e1df.zip
52533-080	FENTANYL CITRATE, BUPIVACAINE HCL INJECTION, SOLUTION [CANTRELL DRUG COMPANY]	3	Legacy NDC, 1 package rows	20140813_17606e46-f2c4-4821-b67d-a76b41a227e1.zip
52533-080	FENTANYL CITRATE, BUPIVACAINE HCL INJECTION, SOLUTION [CANTRELL DRUG COMPANY]	2	Legacy NDC, 1 package rows	20150113_2eb63a37-acd7-4b8a-a002-48e5060a703d.zip

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
MUN5LYG46H	FENTANYL CITRATE	990-73-8	FENTANYL CITRATE
7TQO7W3VT8	BUPIVACAINE HYDROCHLORIDE	73360-54-0	BUPIVACAINE HYDROCHLORIDE

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Status
52533-080-11	52533008011	250 mL in 1 BAG	250 ml	Historical
52533-080-61	52533008061	250 mL in 1 BAG	250 ml	Historical
52533-080-64	52533008064	125 mL in 1 BAG	125 ml	Historical
52533-080-75	52533008075	100 mL in 1 BAG	100 ml	Historical

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
Fentanyl Citrate, Bupivacaine HCl	Cantrell Drug Company	2015-01-12	HUMAN PRESCRIPTION DRUG LABEL	5
Fentanyl Citrate, Bupivacaine HCl	Cantrell Drug Company	2015-01-12	HUMAN PRESCRIPTION DRUG LABEL	2
Fentanyl Citrate, Bupivacaine HCl	Cantrell Drug Company	2014-08-13	HUMAN PRESCRIPTION DRUG LABEL	8
Fentanyl Citrate, Bupivacaine HCl	Cantrell Drug Company	2014-08-13	HUMAN PRESCRIPTION DRUG LABEL	3